TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

27 hedge funds and large institutions have $12.6M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RJA
1
Raymond James & Associates
Florida
$166K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$265K
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$124K
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$72K
5
Creative Planning
5
Creative Planning
Kansas
$60K

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$1.09M
2
CS
2
Candriam SCA
Luxembourg
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$336K
4
Wells Fargo
4
Wells Fargo
California
$7K
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$230K
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
26
Acrospire Investment Management
Illinois
$1K 305 -887 -74%
CS
27
Candriam SCA
Luxembourg
– – -143,000 Closed
PA
28
Perceptive Advisors
New York
– – -50 Closed
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
– – -3 Closed
Morgan Stanley
30
Morgan Stanley
New York
$0 4 +4 New
1
2